Sign in

CIK 0001829802

  • Emerging growth company

Faeth Therapeutics, Inc.

Sign in to watch
Ticker
FTH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 512-200-2982
Business address
701 TILLERY STREET #12 #1010, AUSTIN, TX, 78702
Former names
Sensei Biotherapeutics, Inc.
  1. 4 Open-market buy 10% owner bought 2,000 shares at $14.00 ($28,000)
  2. 4 Open-market buy Director bought 2,000 shares at $14.00 ($28,000)
  3. 4 Open-market buy Director bought 2,000 shares at $14.00 ($28,000)
  4. 4 Open-market buy 10% owner bought 2,000 shares at $14.00 ($28,000)
  5. 4 Derivatives Options or other derivatives
  6. 3 Insider Initial Statement of Ownership
  7. 4 Open-market buy 10% owner bought 1,000 shares at $14.00 ($14,000)
  8. 4 Open-market buy Director bought 1,000 shares at $14.00 ($14,000)
  9. 4 Open-market buy 10% owner bought 2,000 shares at $12.00 ($24,000)
  10. 4 Open-market buy Director bought 2,000 shares at $12.00 ($24,000)
  11. 4 Open-market buy Director bought 3,750 shares at $14.12 ($52,950)
  12. 4 Open-market buy 10% owner bought 3,750 shares at $14.12 ($52,950)
  13. 4 Open-market buy Director bought 10,000 shares at $14.34 ($143,400)
  14. 4 Open-market buy 10% owner bought 10,000 shares at $14.34 ($143,400)
  15. 4 Open-market buy 10% owner bought 2,183 shares at $15.02 ($32,789)
  16. 4 Open-market buy Director bought 2,183 shares at $15.02 ($32,789)
  17. 4 Open-market buy 10% owner bought 817 shares at $15.25 ($12,459)
  18. 4 Open-market buy Director bought 817 shares at $15.25 ($12,459)
  19. 4 Open-market buy Director bought 1,000 shares at $15.25 ($15,249)
  20. 4 Open-market buy 10% owner bought 1,000 shares at $15.25 ($15,249)

Page 10 of 13 · 245 filings